David A. Braun, MD, PhD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
David Braun, MD, PhD, is an Assistant Professor of Medicine (Medical Oncology) and a member of the Center of Molecular and Cellular Oncology (CMCO) at Yale Cancer Center. Dr. Braun cares for patients with kidney cancers. He received his PhD in Computational Biology from the Courant Institute of Mathematical Science at New York University and his medical degree from Icahn School of Medicine at Mount Sinai. He completed his residency at the Brigham and Women’s Hospital where he received the Dunn Medical Intern Award and served as Chief Medical Resident before completing fellowship training in adult oncology through the Dana-Farber/Partners CancerCare program where he was appointed the Emil Frei Fellow and the John R. Svenson Fellow.
Dr. Braun joined Yale from Dana-Farber Cancer Institute where he was an Instructor in Medicine with clinical and scientific interest in understanding and improving immune therapies for kidney cancer. He has a longstanding interest in integrating experimental and computational approaches to biomedical research and is currently studying mechanisms of response and resistance to immune therapy in kidney cancer, with the goal of developing novel therapies. He continues this work as part of the CMCO, which fosters and mentors physician-scientists as they advance their laboratory-based research programs to bridge fundamental cancer biology with clinical investigation for the translation of basic discoveries into better treatments or diagnosis.
Education & Training
- InstructorHarvard Medical School (2021)
- PhysicianDana-Farber Cancer Institute (2021)
- Postdoctoral FellowDana-Farber Cancer Institute / Harvard Medical School (2019)
- Chief Medical ResidentBrigham and Women’s Hospital / Harvard Medical School (2017)
- Clinical FellowDana-Farber Cancer Institute / Massachusetts General Hospital / Brigham and Women’s Hospital / Harvard Medical School (2016)
- ResidentBrigham and Women’s Hospital / Harvard Medical School (2015)
- InternBrigham and Women’s Hospital / Harvard Medical School (2014)
- MDIcahn School of Medicine at Mount Sinai (2013)
- PhDCourant Institute of Mathematical Sciences at New York University, Computational Biology (2012)
- ABPrinceton University, Molecular Biology (2006)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
R37 MERIT Award | National Institutes of Health / National Cancer Institute (NIH/NCI) | 2023 |
Idea Development Award | Department of Defense | 2023 |
Young Physician-Scientist Award | American Society of Clinical Investigation (ASCI) | 2023 |
Trailblazer Award | Kidney Cancer Association | 2022 |
Goodman and Gilman Yale Scholar | Yale School of Medicine | 2022 |
Spatial Multiomics Award | Akoya Biosciences | 2021 |
Sparkathon: Emerging Leaders Igniting Innovation | Society for Immunotherapy of Cancer (SITC) | 2021 |
1st Runner-Up, Clinician Scientist | Immuno-Oncology Young Investigator Forum | 2021 |
Next Gen Innovator Award | HemOnc Today | 2019 |
John R. Svenson Fellowship | Dana-Farber Cancer Institute | 2019 |
Emil Frei Fellowship | Dana-Farber Cancer Institute | 2018 |
Fellowship Award for Medical Oncology | Brigham and Women’s Hospital / Harvard Medical School | 2016 |
Resident Mentor Award | Brigham and Women’s Hospital / Harvard Medical School | 2015 |
Dunne Medical Internal Award | Brigham and Women’s Hospital / Harvard Medical School | 2014 |
Dr. Barry Coller Award for Excellence in Clinical Medicine | Icahn School of Medicine at Mount Sina | 2013 |
Distinction in Medical Education | Icahn School of Medicine at Mount Sinai | 2012 |
Alpha Omega Alpha | Icahn School of Medicine at Mount Sinai | 2012 |
Excellence in Medicine Leadership Award | American Medical Association Foundation | 2008 |
Graduate School Award for Outstanding Leadership | Mount Sinai School of Medicine | 2008 |
Sanfurd Bluestein, MD Scholarship | Mount Sinai School of Medicine | 2007, 2008, 2009, 2010, 2011 |
Professional Service
Organization | Role | Date |
---|---|---|
European Society for Medical Oncology (ESMO) Scientific Committee for Investigational Immunotherapy Track | Member | 2022 |
Kidney Caner Association Think Tank | Participant | 2021 |
Department of Defense Congressionally Directed Medical Research Program Scientific Review Panel | Member | 2020 - 2021 |
Kidney Cancer Research Summit Steering Committee | Committee Member | 2019 - 2020 |
Hoosier Cancer Research Network Correlative Science Clinical Trial Working Group | Member | 2019 - Present |
American Physician Scientist Association | President | 2009 - 2010 |
Departments & Organizations
- Cancer Immunology
- Center of Molecular and Cellular Oncology
- Computational Biology and Biomedical Informatics
- Human and Translational Immunology Program
- Immunology
- Internal Medicine
- Janeway Society
- Medical Oncology
- Molecular Medicine, Pharmacology, and Physiology
- Pathology
- Program in Translational Biomedicine (PTB)
- Prostate & Urologic Cancers Program
- Skin & Kidney Cancer Program
- Subset Medical Oncology Faculty
- Urology
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine